ATE272392T1 - Verfahren zur kontrolle der liposomengrösse - Google Patents
Verfahren zur kontrolle der liposomengrösseInfo
- Publication number
- ATE272392T1 ATE272392T1 AT00907183T AT00907183T ATE272392T1 AT E272392 T1 ATE272392 T1 AT E272392T1 AT 00907183 T AT00907183 T AT 00907183T AT 00907183 T AT00907183 T AT 00907183T AT E272392 T1 ATE272392 T1 AT E272392T1
- Authority
- AT
- Austria
- Prior art keywords
- solvent
- lipid
- liposome size
- particle size
- lipid solvent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dispersion Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Reproductive Health (AREA)
- Transplantation (AREA)
- Anesthesiology (AREA)
- Emergency Medicine (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11922999P | 1999-02-08 | 1999-02-08 | |
PCT/US2000/003039 WO2000045791A2 (en) | 1999-02-08 | 2000-02-03 | Method for controlling liposome size |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE272392T1 true ATE272392T1 (de) | 2004-08-15 |
Family
ID=22383233
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00907183T ATE272392T1 (de) | 1999-02-08 | 2000-02-03 | Verfahren zur kontrolle der liposomengrösse |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1150658B1 (de) |
JP (1) | JP2002536316A (de) |
KR (1) | KR20010101837A (de) |
CN (1) | CN1198589C (de) |
AT (1) | ATE272392T1 (de) |
AU (1) | AU773515B2 (de) |
CA (1) | CA2361551A1 (de) |
DE (1) | DE60012693T2 (de) |
ES (1) | ES2225094T3 (de) |
HK (1) | HK1040642A1 (de) |
HU (1) | HUP0200421A3 (de) |
IL (2) | IL144756A0 (de) |
NO (1) | NO20013862L (de) |
WO (1) | WO2000045791A2 (de) |
ZA (1) | ZA200106444B (de) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7718189B2 (en) | 2002-10-29 | 2010-05-18 | Transave, Inc. | Sustained release of antiinfectives |
US7879351B2 (en) * | 2002-10-29 | 2011-02-01 | Transave, Inc. | High delivery rates for lipid based drug formulations, and methods of treatment thereof |
AU2003287526A1 (en) * | 2002-11-06 | 2004-06-03 | Protein-stabilized liposomal formulations of pharmaceutical agents | |
JP5107573B2 (ja) * | 2003-04-25 | 2012-12-26 | ザ ペン ステイト リサーチ ファウンデーション | 増殖抑制性脂質由来生物活性化合物の全身送達方法およびシステム |
JP2006193461A (ja) * | 2005-01-13 | 2006-07-27 | Pola Chem Ind Inc | 毛髪用の洗浄料 |
KR100684380B1 (ko) * | 2005-05-24 | 2007-02-20 | 한국화학연구원 | 빗살형 폴리에틸렌글리콜을 결합한 리포솜 및 이의 제조방법 |
CA2838111C (en) | 2005-12-08 | 2016-01-19 | Insmed Incorporated | Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof |
ES2668554T3 (es) * | 2006-04-06 | 2018-05-18 | Insmed Incorporated | Métodos para la encapsulación liposomal inducida por coacervación y sus formulaciones |
US20100196455A1 (en) | 2007-05-04 | 2010-08-05 | Transave, Inc. | Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof |
US9114081B2 (en) | 2007-05-07 | 2015-08-25 | Insmed Incorporated | Methods of treating pulmonary disorders with liposomal amikacin formulations |
US9119783B2 (en) | 2007-05-07 | 2015-09-01 | Insmed Incorporated | Method of treating pulmonary disorders with liposomal amikacin formulations |
US9333214B2 (en) | 2007-05-07 | 2016-05-10 | Insmed Incorporated | Method for treating pulmonary disorders with liposomal amikacin formulations |
WO2010010985A1 (en) | 2008-07-24 | 2010-01-28 | Amorepacific Corporation | Multi-layered lamellar granule and skin external application composition containing same |
EA201170286A1 (ru) * | 2008-12-24 | 2011-10-31 | Байомедкор Инк. | Способ получения липосом и способ растворения холестерина |
JP5771366B2 (ja) * | 2009-09-02 | 2015-08-26 | 株式会社バイオメッドコア | リポソーム製造装置及び方法 |
JP5881042B2 (ja) * | 2010-06-23 | 2016-03-09 | 学校法人神奈川大学 | 乳化物製造用親水性ナノ粒子の製造方法 |
KR101130754B1 (ko) * | 2010-06-25 | 2012-03-28 | 제일약품주식회사 | 난용성 트리사이클릭 유도체 화합물의 용해도가 향상된 약학적 조성물 |
CN108743537B (zh) | 2012-05-21 | 2021-06-11 | 英斯麦德公司 | 治疗肺部感染的系统 |
US9820940B2 (en) * | 2012-08-17 | 2017-11-21 | University Of Houston System | Liposomal formulations of polymyxin and uses thereof |
JP6332902B2 (ja) * | 2012-10-29 | 2018-05-30 | 株式会社ピカソ美化学研究所 | 美容用組成物 |
CN104884047A (zh) | 2012-11-29 | 2015-09-02 | 英斯梅德股份有限公司 | 稳定的万古霉素制剂 |
CA2922002A1 (en) | 2013-09-13 | 2015-03-19 | Arbor Therapeutics, LLC | Nanoparticulate compositions for targeted delivery of lipophilic drugs and acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation |
MX2016014921A (es) | 2014-05-15 | 2017-07-28 | Insmed In Incorporated | Metodos para tratar infecciones pulmonares micobacterianas no tuberculosas. |
CN111565833B (zh) * | 2017-11-01 | 2023-04-07 | 国立大学法人大阪大学 | 用于制造具有期望的粒径的脂质颗粒的方法及装置的开发 |
US11571386B2 (en) | 2018-03-30 | 2023-02-07 | Insmed Incorporated | Methods for continuous manufacture of liposomal drug products |
CN114588125B (zh) * | 2022-02-25 | 2023-02-28 | 北京科技大学 | 靶向载药溶栓微泡及其制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61189215A (ja) * | 1985-02-18 | 1986-08-22 | Teijin Ltd | 5−フルオロ−2′−デオキシウリジンエステル類の油状医薬組成物 |
DE4013580A1 (de) * | 1990-04-24 | 1991-10-31 | Schering Ag | Verfahren zur herstellung von wirkstoffhaltigen waessrigen liposomensuspensionen |
RU2085192C1 (ru) * | 1993-02-03 | 1997-07-27 | Экспериментальное предприятие медико-биологических препаратов Кардиологического научного центра РАМН | Способ получения липосомальной формы альфа-токоферола и гомогенизирующий клапан для его осуществления |
DK0707472T3 (da) * | 1993-07-08 | 2001-04-17 | Liposome Co Inc | Fremgangsmåde til regulering af størrelsen af liposomer |
US5902604A (en) * | 1995-06-06 | 1999-05-11 | Board Of Regents, The University Of Texas System | Submicron liposome suspensions obtained from preliposome lyophilizates |
AU7983798A (en) * | 1997-06-23 | 1999-01-04 | Sequus Pharmaceuticals, Inc. | Liposome-entrapped polynucleotide composition and method |
-
2000
- 2000-02-03 CA CA002361551A patent/CA2361551A1/en not_active Abandoned
- 2000-02-03 KR KR1020017010024A patent/KR20010101837A/ko not_active Application Discontinuation
- 2000-02-03 JP JP2000596911A patent/JP2002536316A/ja active Pending
- 2000-02-03 IL IL14475600A patent/IL144756A0/xx active IP Right Grant
- 2000-02-03 CN CNB008035075A patent/CN1198589C/zh not_active Expired - Fee Related
- 2000-02-03 HU HU0200421A patent/HUP0200421A3/hu unknown
- 2000-02-03 AT AT00907183T patent/ATE272392T1/de not_active IP Right Cessation
- 2000-02-03 EP EP00907183A patent/EP1150658B1/de not_active Expired - Lifetime
- 2000-02-03 ES ES00907183T patent/ES2225094T3/es not_active Expired - Lifetime
- 2000-02-03 WO PCT/US2000/003039 patent/WO2000045791A2/en not_active Application Discontinuation
- 2000-02-03 DE DE2000612693 patent/DE60012693T2/de not_active Expired - Fee Related
- 2000-02-03 AU AU28718/00A patent/AU773515B2/en not_active Ceased
-
2001
- 2001-08-06 IL IL144756A patent/IL144756A/en not_active IP Right Cessation
- 2001-08-06 ZA ZA200106444A patent/ZA200106444B/xx unknown
- 2001-08-08 NO NO20013862A patent/NO20013862L/no not_active Application Discontinuation
-
2002
- 2002-04-04 HK HK02102545A patent/HK1040642A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HK1040642A1 (en) | 2002-06-21 |
NO20013862D0 (no) | 2001-08-08 |
NO20013862L (no) | 2001-10-08 |
CA2361551A1 (en) | 2000-08-10 |
HUP0200421A2 (en) | 2002-06-29 |
DE60012693D1 (de) | 2004-09-09 |
AU2871800A (en) | 2000-08-25 |
ZA200106444B (en) | 2002-08-06 |
HUP0200421A3 (en) | 2005-04-28 |
ES2225094T3 (es) | 2005-03-16 |
EP1150658A2 (de) | 2001-11-07 |
CN1338923A (zh) | 2002-03-06 |
EP1150658B1 (de) | 2004-08-04 |
CN1198589C (zh) | 2005-04-27 |
WO2000045791A2 (en) | 2000-08-10 |
DE60012693T2 (de) | 2005-01-13 |
JP2002536316A (ja) | 2002-10-29 |
AU773515B2 (en) | 2004-05-27 |
IL144756A0 (en) | 2002-06-30 |
WO2000045791A3 (en) | 2000-12-21 |
KR20010101837A (ko) | 2001-11-14 |
IL144756A (en) | 2007-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE272392T1 (de) | Verfahren zur kontrolle der liposomengrösse | |
DE69624485D1 (de) | Verfahren zur herstellung hydro-monobenzoporhyrin -photosensibilisatoren enthaltender liposomen | |
CA2386577A1 (en) | System and method for making wallboard or backerboard sheets including aerated concrete | |
ATE203898T1 (de) | Verfahren zur herstellung einer liposomen- zubereitung | |
DE69938875D1 (de) | ||
IE801201L (en) | Cementitious product. | |
PL326485A1 (en) | Compositions for obtaining light-weight gypsum, method of obtaining an expanding agent and application thereof | |
PT76245B (de) | Verfahren zur herstellung von unilamellaren liposomen in waessriger phase | |
DE60142487D1 (de) | Verfahren zur herstellung von liposomen | |
MY135654A (en) | Process for the preparation of a dry pesticidal composition containing a water-soluble salt of glyphosate acid and a dicarboxylate component | |
DE69522517D1 (de) | Verfahren zur Herstellung von verstärkten Steinplatten | |
DE69512275D1 (de) | Verfahren zur anwendung von giessmaterial mit niedrigem zementgehalt | |
DE69125035D1 (de) | Verfahren zur herstellung von interferon-alpha-2 kristallen | |
ES2147201T3 (es) | Metodo para fabricar un producto de piedra en forma de plancha. | |
ATE150784T1 (de) | Bodenverbesserungsmittel sowie verfahren zu seiner herstellung | |
ATE172948T1 (de) | Tontauben und verfahren zu ihrer herstellung | |
DE69309819D1 (de) | Verfahren zur Herstellung eines supraleitenden Materialgemisches, das seltene Erdelemente enthält | |
DE69701730T2 (de) | Verfahren zur herstellung von mörtel | |
DE60008234D1 (de) | Liposomenzusammensetzungen zur verbesserten wirkstoffzurückhaltung | |
WO2000045845A3 (en) | Liposome composition and method for administration of a radiosensitizer | |
TW222257B (en) | Sprayable fireproofing compositions | |
DE69532533D1 (de) | Verfahren zur herstellung von ranitidin | |
DE3669151D1 (de) | Verfahren zur herstellung von 2-acyl-3,4-alkoxyanilinen. | |
ATE153624T1 (de) | Doppelplatte und verfahren zu ihrer herstellung | |
JPS5910320B2 (ja) | 人造石 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |